253
Participants
Start Date
February 29, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
April 30, 2009
CF101
orally q12h
Placebo
orally q12h
Clinic of Rheumatology at MHAT 'Sveti Ivan Rilski', Sofia
Clinic of Rheumatology at MHAT 'Sveti Georgi', Plovdiv
Second Clinic of Internal Diseases at MHAT 'Stara Zagora', Stara Zagora
Clinic of Rheumatology at MHAT 'Sveta Marina' - Varna, Varna
Institute of Rheumatology - Belgrade, Belgrade
Institute of Rheumatology, Prague
Institute for Prevention, Treatment, and Rehabilitation of Rheumatoid and Cardiovascular Diseases Niska Banja, Niška Banja
Niepubliczny Zaklad Opieki Zdrowotnej, Lublin
Vinnitsya Regional Clinical Hospital, Vinnycia
Rambam Medical Center, Haifa
Meir Medical Center, Kfar Saba
University Hospital Hradec Kralove, Hradec Králové
Samodzielny Publiczny Szpital Kliniczny Nr 1 P.A.M. w Szczecinie, Szczecin
Rheumotology Out-patient Clinic, Zlín
Barzilai Medical Center, Ashkelon
Wojewodzki Zespol Reumatologiczny w Sopocie, Sopot
Wojewodzki Szpital Zespolony w Elblagu, Elblag
Central Municipal Clinical Hospital nº1, Donetsk
"Niepubliczny Zaklad Opieki Zdrowotnej NASZ LEKARZ", Torun
Clinic of internal diseases at NMTH 'Tzar Boris Treti', Sofia
Haemek Medical Center, Afula
Hadassah Har-Hazofim Medical Center, Jerusalem
Kyiv Central Municipal Hospital, Kiev
City Clinical Hospital N12, Kiev
National Scientific Centre of AMS of Ukraine, Kiev
O.O. Bogomolets National Medical University, Kiev
Lead Sponsor
Can-Fite BioPharma
INDUSTRY